Double maintains 1 strategies that include NVS - Novartis AG
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
AZN | 61.68% | $210.76B | -11.79% | 2.28% |
GSK | 59.74% | $76.12B | -16.29% | 4.20% |
UL | 54.52% | $154.65B | +14.37% | 3.06% |
JNJ | 53.35% | $360.54B | -3.03% | 3.32% |
KO | 52.75% | $308.23B | +13.09% | 2.75% |
ABT | 52.31% | $232.01B | +27.16% | 1.71% |
AMGN | 52.23% | $146.09B | -13.67% | 3.40% |
PFE | 52.22% | $128.49B | -21.85% | 7.56% |
HLN | 52.16% | $48.13B | +27.48% | 1.59% |
O | 50.61% | $50.03B | +0.38% | 5.73% |
ATO | 49.53% | $24.77B | +31.55% | 2.15% |
MMC | 49.10% | $111.97B | +8.65% | 1.43% |
SNY | 48.76% | $123.92B | +4.18% | 4.34% |
AWK | 48.74% | $27.37B | +4.54% | 2.22% |
BIIB | 48.52% | $18.13B | -46.23% | 0.00% |
SO | 47.99% | $96.04B | +10.08% | 3.29% |
DTE | 47.97% | $28.28B | +16.72% | 3.10% |
NSA | 47.96% | $2.71B | -6.34% | 6.35% |
AEP | 47.95% | $54.28B | +9.80% | 3.61% |
POR | 47.95% | $4.62B | -6.78% | 4.75% |
SeekingAlpha
Pfizer's Turnaround Story Is Stronger Than You Think
Yahoo
NATALEE subanalysis evaluates Kisqali in pre-menopausal early breast cancer patients, amid rising diagnosis rates in younger patients Pluvicto analysis and Scemblix ASC4START primary endpoint results provide insights into use in earlier settingsFabhalta APPULSE-PNH full results build on Phase III program, reporting new data from expanded PNH population in adults switching from anti-C5Ianalumab Phase II data in immune thrombocytopenia and longer-term pelabresib Phase III data in myelofibrosis sho
Yahoo
Through the Boston Pharma deal, GSK aims to strengthen its pipeline, as some of its key products are nearing the end of their exclusivity period.
SeekingAlpha
VEU is a top low-cost ETF for global diversification beyond U.S. stocks and the U.S. dollar. Click here to see why the Fund is a Buy.
SeekingAlpha
The fund posted returns of -1.02% (Institutional shares) and -1.07% (Investor A shares, without sales charge) for the first quarter of 2025.
SeekingAlpha
Recursion Pharmaceuticals: High-Risk Play Getting Riskier By The Quarter
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
PPH | 71.61% | $626.20M | 0.36% |
EWL | 69.85% | $1.21B | 0.5% |
IXJ | 67.91% | $3.78B | 0.41% |
EFAV | 62.02% | $5.28B | 0.2% |
ACWV | 60.89% | $3.38B | 0.2% |
KXI | 60.57% | $822.83M | 0.41% |
XLV | 60.22% | $34.49B | 0.09% |
HDEF | 60.11% | $1.95B | 0.09% |
IYH | 59.26% | $2.78B | 0.39% |
GCOW | 59.10% | $2.21B | 0.6% |
DWX | 58.91% | $457.66M | 0.45% |
VHT | 58.59% | $14.92B | 0.09% |
FHLC | 58.29% | $2.42B | 0.084% |
NFRA | 58.07% | $2.38B | 0.47% |
SCHY | 57.97% | $1.03B | 0.08% |
HDV | 57.31% | $10.94B | 0.08% |
EWU | 57.01% | $3.16B | 0.5% |
IYK | 56.84% | $1.48B | 0.4% |
SPLV | 56.70% | $7.90B | 0.25% |
LVHD | 56.51% | $563.02M | 0.27% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
USL | 0.01% | $41.76M | 0.85% |
CRPT | -0.06% | $108.88M | 0.85% |
SGOV | 0.23% | $45.91B | 0.09% |
XHLF | -0.30% | $1.46B | 0.03% |
CANE | 0.37% | $10.71M | 0.29% |
DBE | -0.38% | $48.48M | 0.77% |
GBIL | 0.38% | $6.17B | 0.12% |
BNO | 0.46% | $86.13M | 1% |
UNG | -0.57% | $371.83M | 1.06% |
BKCH | -0.66% | $157.69M | 0.5% |
UGA | -0.80% | $73.47M | 0.97% |
OILK | 0.87% | $63.21M | 0.69% |
USO | 0.89% | $956.18M | 0.6% |
SATO | -0.91% | $10.74M | 0.6% |
BITQ | -1.18% | $197.52M | 0.85% |
DAPP | -1.20% | $189.23M | 0.51% |
CONY | -1.25% | $1.16B | 1.22% |
ULST | -1.36% | $637.77M | 0.2% |
YBTC | -1.58% | $190.72M | 0.95% |
ARKW | 1.71% | $1.71B | 0.82% |
Current Value
$107.991 Year Return
Current Value
$107.991 Year Return
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
EE | -0.01% | $935.91M | +57.00% | 0.58% |
APOG | -0.02% | $877.55M | -37.72% | 3.09% |
KRNT | 0.04% | $1.01B | +45.96% | 0.00% |
CPRI | 0.04% | $2.18B | -48.85% | 0.00% |
CASI | 0.05% | $28.04M | -44.22% | 0.00% |
OWL | 0.09% | $12.09B | +2.33% | 4.91% |
CVNA | -0.10% | $40.16B | +152.18% | 0.00% |
NU | -0.10% | $63.27B | +12.13% | 0.00% |
SMLR | 0.10% | $354.51M | +34.30% | 0.00% |
NRG | -0.11% | $30.31B | +86.93% | 1.09% |
VLRS | -0.11% | $496.82M | -49.18% | 0.00% |
HUSA | -0.14% | $9.73M | -55.71% | 0.00% |
NEO | -0.14% | $1.01B | -47.70% | 0.00% |
MODV | -0.14% | $12.77M | -96.80% | 0.00% |
AAON | -0.14% | $8.47B | +39.07% | 0.32% |
FLEX | 0.15% | $16.07B | +43.86% | 0.00% |
ALAR | 0.15% | $55.19M | -71.11% | 0.00% |
CNM | 0.16% | $9.95B | -13.57% | 0.00% |
HIMS | -0.16% | $13.11B | +317.24% | 0.00% |
DXPE | 0.19% | $1.40B | +74.66% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
USDU | -25.17% | $173.44M | 0.5% |
UUP | -24.25% | $292.27M | 0.77% |
VIXY | -21.85% | $109.64M | 0.85% |
TAIL | -19.15% | $140.49M | 0.59% |
TESL | -8.62% | $30.66M | 1.2% |
TPMN | -8.59% | $31.54M | 0.65% |
KCCA | -8.24% | $97.18M | 0.87% |
EETH | -7.61% | $67.45M | 0.95% |
CLIP | -7.29% | $1.50B | 0.07% |
BTF | -6.76% | $35.22M | 1.25% |
CTA | -6.71% | $1.05B | 0.76% |
CETH | -6.69% | $24.05M | 0% |
FETH | -6.66% | $1.08B | 0.25% |
ETHV | -6.56% | $123.08M | 0% |
ETHA | -6.52% | $3.38B | 0.25% |
EZET | -6.46% | $34.72M | 0% |
ETH | -6.43% | $1.13B | 0% |
QETH | -6.42% | $22.91M | 0.25% |
ETHW | -6.19% | $250.22M | 0% |
ETHE | -5.85% | $3.04B | 2.5% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
AIFU | -15.15% | $9.85M | -95.03% | 0.00% |
STRL | -11.86% | $5.62B | +42.14% | 0.00% |
TLN | -11.64% | $11.14B | +126.67% | 0.00% |
MYRG | -11.36% | $2.54B | +7.70% | 0.00% |
ALAB | -11.15% | $15.20B | +26.29% | 0.00% |
ANF | -10.27% | $3.79B | -41.29% | 0.00% |
RDDT | -9.99% | $20.96B | +101.47% | 0.00% |
PRIM | -9.86% | $4.08B | +49.66% | 0.37% |
POWL | -9.84% | $2.15B | +8.63% | 0.44% |
ANET | -9.83% | $120.66B | +20.05% | 0.00% |
CEG | -9.54% | $89.14B | +31.46% | 0.51% |
MRVL | -9.17% | $56.32B | -10.78% | 0.37% |
LMB | -9.02% | $1.42B | +153.39% | 0.00% |
CCRN | -8.88% | $457.33M | -5.30% | 0.00% |
VRT | -8.47% | $40.16B | +8.32% | 0.12% |
FVRR | -8.39% | $1.14B | +26.26% | 0.00% |
LITE | -8.35% | $5.40B | +66.15% | 0.00% |
COHR | -8.18% | $12.25B | +35.13% | 0.00% |
UTI | -8.09% | $1.84B | +121.04% | 0.00% |
FIX | -8.08% | $16.35B | +44.08% | 0.23% |